-
Red Blood Cell Lysis Buffer: Enabling Advanced Cell Purity f
2026-05-03
Explore how Red Blood Cell Lysis Buffer empowers precise erythrocyte removal, unlocking high-purity cell populations essential for advanced osteogenic and immunological assays. This article offers a deep dive into technical mechanisms, evidence-based protocols, and unique cross-talk with RUNX2 signaling insights.
-
Erastin as a Ferroptosis Inducer: Protocols, Use-Cases, and
2026-05-02
Erastin, a small molecule ferroptosis inducer, offers cancer and redox biology labs a precision tool for dissecting iron-dependent cell death mechanisms in RAS/BRAF mutant models. This article delivers practical workflows, troubleshooting tactics, and actionable insights informed by recent discoveries and validated protocols.
-
Perphenazine (SKU B6157): Data-Driven Solutions for Cell Ass
2026-05-02
This article provides a scenario-driven, evidence-based exploration of Perphenazine (SKU B6157) as a dopamine D2 receptor antagonist for advanced cell viability, proliferation, and cytotoxicity assays. Drawing on quantitative data and recent literature, it guides researchers on protocol optimization, data interpretation, and vendor reliability—demonstrating why APExBIO’s Perphenazine is a robust choice for reproducible and innovative laboratory workflows.
-
Chicken GSDME Drives Pyroptosis in RNA Virus-Infected Avian
2026-05-01
This study identifies chicken GSDME (chGSDME) as the principal mediator of pyroptosis in response to RNA virus infection in avian cells, revealing a unique molecular pathway distinct from the GSDMD-dependent mechanism in mammals. The findings advance understanding of host-pathogen interactions in birds and open new avenues for dissecting programmed cell death in non-mammalian systems.
-
Distinct Cell Death Pathways in ALL Cells Upon Microtubule D
2026-04-30
This study reveals that primary acute lymphoblastic leukemia (ALL) cells undergo distinct cell death mechanisms when exposed to microtubule depolymerization during different cell cycle phases. These mechanistic insights refine our understanding of how microtubule-targeting agents (MTAs) function and highlight the importance of phase-specific cell death pathways for optimizing cancer therapies.
-
Dabigatran (Pradaxa): Precision Anticoagulation for Coagulat
2026-04-30
Dabigatran, supplied by APExBIO, sets the gold standard for in vitro direct thrombin inhibition, enabling reproducible, high-specificity studies in coagulation function and drug discovery. This guide delivers protocol enhancements, troubleshooting strategies, and comparative insights that empower researchers to achieve data-driven anticoagulation workflows.
-
TRPV1+ Nerve Stimulation Drives Anti-Inflammatory Reflexes
2026-04-29
Song et al. (2025) demonstrate that targeted stimulation of TRPV1+ peripheral sensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation. Their work uncovers a neural-immune circuit with translational potential for inflammation models and therapeutic approaches.
-
Red Blood Cell Lysis Buffer: Precision in Blood Sample Prep
2026-04-29
Unlock high-fidelity blood sample preparation with APExBIO's Red Blood Cell Lysis Buffer, engineered for selective erythrocyte removal while preserving nucleated cell integrity. Streamline workflows for flow cytometry, nucleic acid, and protein extraction with robust, reproducible results.
-
N1-Methylpseudouridine (B8340): Reliable mRNA Translation En
2026-04-28
This article provides an evidence-based, scenario-driven analysis of N1-Methylpseudouridine (SKU B8340) for cell viability, proliferation, and cytotoxicity assays. By addressing common laboratory challenges and integrating literature-backed performance metrics, we demonstrate how this modified nucleoside from APExBIO enables reproducible, low-immunogenicity mRNA workflows.
-
Roscovitine (Seliciclib): Selective CDK Inhibition & Cell Cy
2026-04-28
Roscovitine (Seliciclib, CYC202) is a potent, selective cyclin-dependent kinase inhibitor used to induce cell cycle arrest in late prophase and inhibit tumor growth in vivo. Its well-characterized mechanism and reversibility make it a benchmark compound for dissecting CDK signaling in cancer biology research.
-
CH 223191: Advancing Precision in AhR Pathway Inhibition
2026-04-27
Explore how CH 223191, a potent aryl hydrocarbon receptor antagonist, enables precise dissection of the AhR signaling pathway in environmental toxicology and regenerative research. This article delivers deep assay guidance, unique mechanistic insights, and practical decision support for advanced applications.
-
USP42 Drives Breast Cancer Progression via JNK/p38 Apoptosis
2026-04-27
The referenced study uncovers how USP42, a deubiquitinating enzyme, fosters breast cancer progression by suppressing JNK/p38-mediated apoptosis. These mechanistic insights position USP42 as a promising molecular target and clarify its impact on tumor cell survival and proliferation.
-
7ACC2 (SKU B4868): Reliable MCT1 Inhibitor for Cancer Metabo
2026-04-26
This article addresses persistent challenges in cancer metabolism assays and cell viability studies, highlighting how 7ACC2 (SKU B4868) from APExBIO delivers reproducible, data-driven solutions as a monocarboxylate transporter 1 inhibitor. Through scenario-driven Q&A, we clarify assay design, protocol optimization, data interpretation, and vendor reliability, supporting scientists in leveraging 7ACC2 for robust research outcomes.
-
Anlotinib Hydrochloride: Multi-Target TKI for Angiogenesis A
2026-04-25
Anlotinib hydrochloride empowers cancer researchers with nanomolar, selective inhibition of VEGFR2, PDGFRβ, and FGFR1, streamlining functional angiogenesis assays and surpassing legacy TKIs in both potency and reproducibility. This guide delivers actionable protocols, troubleshooting insights, and comparative data for robust experimental design.
-
Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio
2026-04-24
This study identifies ATG9A and PTOV1 as previously unrecognized binding partners of 14-3-3 proteins, elucidating their distinct regulatory roles in autophagy and oncogenic signaling. The findings provide new mechanistic insights into basal autophagy and the stability of cancer-associated proteins, opening avenues for targeted therapeutic research.